LOXL1 and hepatocellular carcinoma: The GO analysis revealed that among patients with hepatocellular carcinoma, the cell cycle‐related GO terms were significantly upregulated in patients with LOXL1‐mutant tumours than in patients with LOXL1‐non‐mutant tumours, and similar outcomes were observed in GO terms related to mitotic cell cycle, mitotic cell cycle process and cellular response to DNA damage (Figure 5F).